K-numberK253917
Device nameARION ARC System
ApplicantPlasma Surgical, Inc.
Product codeGEI
Device classClass II
Decision dateApr 10, 2026
DecisionSubstantially Equivalent
Regulation
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The ARION ARC System is a plasma-based surgical device intended for soft tissue coagulation during open surgery. It generates argon plasma through an internal arc discharge to create a thin coagulated layer on tissue surfaces, stopping bleeding and reducing fluid loss. The system consists of a generator, trolley, reusable handpiece (rated for 30 uses), and single-use sterile accessories including drapes and spacers.

Technological characteristics

Key differences from the predicate include a reusable handpiece (versus single-use), sterile single-use spacers and drape for maintaining optimal working distance, a reposable design with electrode components rated for minimum 30 uses of 5 minutes each, and enhanced UI with three operational stages including cooldown/shutdown. Both devices use identical argon gas parameters (0.2-0.7 l/min), energy source (30-60V DC), power range (20-170W typical, 300W max), and achieve the same tissue penetration depth (typically 2.5mm).

Test standards cited

Biocompatibility (ISO 10993-1, -5, -9, -10, -11, -12, -23), sterilization validation (ISO 11135, 11138-3, 17665-1, 11607-1, -2), reprocessing validation (ANSI AAMI ST98), electrical safety (IEC 60601-1-1), electromagnetic compatibility (IEC 60601-1-2), human factors/usability (IEC 62366-1), and package performance (ASTM 4169-22, ASTM F88/F88M-23).

Substantial equivalence argument

The ARION ARC System is substantially equivalent to the predicate PlasmaJet System because both devices use identical plasma generation and coagulation principles with the same argon gas parameters, power specifications, and tissue effects. Although the subject device introduces design enhancements (reusable handpiece, sterile spacers, enhanced UI), comprehensive testing demonstrates these differences do not raise new questions of safety or effectiveness. The core mechanism of argon plasma ionization, energy delivery, and tissue interaction remains unchanged.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →